About Xylopia
Xylopia is a company. The company has 111 employees as of April 08, 2024. Xylopia offers products and services including Dosage Form Development and Formulation Research.
- Employees 111 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Xylopia Labs Private Limited
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$3.64 M (USD)2.54as on Mar 31, 2022
-
Net Profit
$397.21 K (USD)0.48as on Mar 31, 2022
-
EBITDA
$689.4 K (USD)43.83as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
111
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xylopia
Xylopia offers a comprehensive portfolio of products and services, including Dosage Form Development and Formulation Research.
Dosage form development services are offered in collaboration with pharmaceutical companies for regulatory programs.
Formulation research services are provided to support drug development initiatives through expert team efforts.
Funding Insights of Xylopia
Detailed funding history for Xylopia
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xylopia
Investment portfolio details for Xylopia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xylopia
Detailed financials for Xylopia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xylopia Comparisons
Peer comparison for Xylopia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xylopia
Detailed competitors of Xylopia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xylopia
Complete news archive for Xylopia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xylopia
As of Apr 08, 2024, the latest employee count at Xylopia is 111.
Annual revenue of Xylopia is $3.64M as on Mar 31, 2022.
Xylopia is recognized as an integrated provider of drug development solutions, where full-service research and development in dosage forms are offered to global pharmaceutical companies. Commitments to client programs are supported by carefully planned infrastructure and equipment, along with a team of experienced members who ensure high-quality deliverables in formulation and regulatory efforts. Partnerships are established to facilitate competitive-level development, emphasizing value addition through technical competence and reliable services.
Xylopia offers Dosage Form Development and Formulation Research.